Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind crossover patient preference study of frovatriptan versus rizatriptan in acute migraine
2006-000785-36Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of frovatriptan and rizatriptan in migraine (2 arms), sponsored by Menarini Group. Primary endpoint: Patient preference between frovatriptan and rizatriptan. Started Mar 2007; status: completed.
02
Drugs
frovatriptanrizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2006-000785-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000785-36.